China Equity Index Funds in 2018 Q2: Product Growth and Performance
Summary
This quarterly review examines China's equity index fund market in the second quarter of 2018. It describes faster ETF and LOF product development across broad-market and sector indexes, alongside the shrinking assets of leveraged graded funds. The report also highlights a wave of MSCI China A-share fund launches and argues that enhanced index products could grow by seeking excess returns while controlling tracking error. It presents fund counts, assets, flows, product launches, and manager concentration as evidence of market structure and activity.
The performance discussion reports that most ETFs declined during the quarter, with consumer and healthcare sectors among the stronger areas; many leveraged B shares also fell, with amplified moves attributed to their leverage. These observations are specific to one historical quarter and do not establish persistent sector or product returns. The report focuses on industry assets and product positioning rather than a replicable investment strategy, and it gives no forward-looking test of enhanced-index performance or investor-level costs.
Key ideas
- ETF and LOF offerings expanded across many broad-market and sector indexes during the quarter.
- MSCI China A-share products were a major focus of new index fund launches.
- The report frames enhanced index funds as competing through excess returns under tracking-error limits.
- Fund assets, flows, launches, and manager concentration describe the market's structure in that period.
- Quarterly sector and leveraged-fund returns are historical observations, not evidence of durable performance.
Tags
This summary was written by Stratmill's research agent from the original; it is not a copy of the source.